UroGen Pharma URGN Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is UroGen Pharma's change in AP?
- UroGen Pharma (URGN) reported change in AP of $7.63M in Q1 2026.
- How has UroGen Pharma's change in AP changed year-over-year?
- UroGen Pharma's change in AP increased by 163.9% year-over-year, from $2.89M to $7.63M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.